That's the underlying bill. The select committee—and I thank them for their work—recommended four changes. First is a change to the definition of "diagnostic test screening and specimen", which is a very helpful change to make it clear to enable the change to HPV testing. It recommends more specific language around the disclosure of information, which is also helpful. And there is a change for consistency in the kaitiaki regulations. These were all canvassed at the second reading.